Special Issue Title:

Cervical Cancer and Novel Interventions

Deadline for manuscript submissions: 15 September 2022

Print Special Issue Flyer (2)

Special Issue Editor

  • Guest Editor

    Yvonne G. Lin, MD, MScE-MailWebsite

    Genentech-Roche, South San Francisco, CA, USA; University of California, San Francisco, CA, USA

    Interests: gynecologic malignancies; innovative clinical trial designs; targeted agents

  • Guest Editor

    Ritu Salani, MD, MBAE-MailWebsite

    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA

    Interests: cervical cancer; novel therapeutics and prevention strategies for gynecologic cancers

  • Guest Editor

    Megan Swanson, MD, MPHE-MailWebsite

    University of California, San Francisco, CA, USA

    Interests: global health; cervical cancer; disparities in access to prevention, treatment, and cancer care

Special Issue Information

Dear Colleagues,

Cervical cancer affects more than 500,000 women worldwide. In recent years, virally driven malignancies such as cervical cancer also represent an increasingly attractive target for immune modulatory therapies. Indeed, vaccines against the most common oncogenic genotypes of the human papilloma virus (HPV) have already demonstrated profound efficacy in the primary prevention of cervical cancer. The years of worldwide HPV vaccination programs coupled with cervical cancer screening programs sponsored by government and non-governmental organizations (NGOs) are finally yielding quantifiable decreases globally in cervical cancer incidence and even death. In addition to these immunization measures that harness the immune system to prevent cancer, an advanced understanding of the immune system and its response to cancer growth and metastasis has produced an expanding set of novel cancer immunotherapies (CITs), some of which can effectively treat and, in some cases, eliminate established cancers, including cervical cancer.

In this Special Issue of the European Journal of Gynaecological Oncology, authors will share their research focusing on novel treatment strategies for cervical cancer that advance our understanding of the interplay between the host response to tumor initiation and progression. Studies may also focus on how predictive biomarkers can be utilized to tailor novel and existing therapies and/or vaccines (preventative or therapeutic) to optimize clinical outcomes. Because of the global nature of cervical cancer, special consideration will be given to studies that present and employ novel research methods to study cervical cancer in diverse resource settings.

Dr. Yvonne G. Lin, Prof. Ritu Salani and Assis. Prof. Megan Swanson

Guest Editors 


cervical cancer;novel treatment and prevention strategies;predictive biomarkers

Manuscript Submission Information

Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access journal published by MRE Press. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.

Share This Special Issue

Published Papers (1 papers)

Open Access Special Issue

Advances of exosomes in the cervical cancer

Li-Na Ke,Xiao-Qiong Tian,Ling-Qi Kong,Qin-Hua Chen,Peng Li,Hong-Mei Wang,Xiao-Hua Zeng

DOI: 10.22514/ejgo.2022.012

(This article belongs to the Special Issue Cervical Cancer and Novel Interventions)

Abstract ( 801 ) PDF (283.56 kB) ( 178 )

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time